Severin Schricker

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne et al. · The Lancet Diabetes & Endocrinology · 2023 · 108 citations · Full text

Medicine, Nephrology, Pharmacotherapy +11

Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial

Natalie Staplin, Richard Haynes, PK Judge et al. · The Lancet Diabetes & Endocrinology · 2023 · 90 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Urinary [TIMP-2]·[IGFBP7]-guided randomized controlled intervention trial to prevent acute kidney injury in the emergency department

Moritz Schanz, Christoph Wasser, Sebastian Allgaeuer et al. · Nephrology Dialysis Transplantation · 2018 · 49 citations

Medicine, Emergency Medicine, Nephrology +15

Endocrinology: von Willebrand factor: an endothelial marker to monitor in-vitro fertilization patients with ovarian hyperstimulation syndrome*

S. Todorow, Severin Schricker, E. Siebzehnruebl et al. · Human Reproduction · 1993 · 32 citations

Medicine, Endocrinology, Gynecology +14

The phenotype of adverse drug effects: Do emergency visits due to adverse drug reactions look different in older people? Results from the ADRED study

Katja S. Just, Harald Dormann, Marlen Schurig et al. · British Journal of Clinical Pharmacology · 2020 · 32 citations · Full text

Medicine, Emergency Medicine, Geriatric Medicine +14